Proximod Pharmacokinetics in Healthy Subjects and Patients With Rheumatoid Arthritis
Status:
COMPLETED
Trial end date:
2023-10-08
Target enrollment:
Participant gender:
Summary
The goal of this clinical trial is to evaluate the tolerability, pharmacokinetics and pharmacodynamics of Proximod in healthy subjects and patients with rheumatoid arthritis. The main questions it arms to answer are:
1. to evaluate the safety and tolerance of Proximod in health subjects after repeated doses.
2. to assess the pharmacokinetics and pharmacodynamics of Proximod in healthy subjects after repeated doses.
3. to evaluate the safety and tolerance of Proximod in patients with rheumatoid arthritis.
4. to evaluate the pharmacokinetics and pharmacodynamics of Proximod in patients with rheumatoid arthritis.
Participants will receive test tablets or placebo at the indicated date and collect blood samples.